PRCT Chart
- 52-Week Range: $0.00 - $0.00
- Market Capitalization: $1.77B
- Short Percentage: 0%
- Target Price: $43.25
- Shares Outstanding: 44.17M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
PRCT released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- PROCEPT BioRobotics (PRCT) CEO Reza Zadno on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha | March 8th
- PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2021 Financial ResultsGlobeNewsWire | March 8th
- PROCEPT Announces 5-Year WATER Study Data Comparing Aquablation to TURPGlobeNewsWire | February 14th
- PROCEPT BioRobotics Corp. Announces Preliminary Fourth Quarter and Fiscal Year 2021 RevenueGlobeNewsWire | January 11th
- PROCEPT BioRobotics' (PRCT) CEO Reza Zadno on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha | November 7th
- PROCEPT BioRobotics Corp. to Report Third Quarter 2021 Financial Results on November 4, 2021GlobeNewsWire | October 21st
- PROCEPT BioRobotics Corporation Announces Cigna Adds Aquablation Therapy to its Coverage PolicyGlobeNewsWire | September 28th
- Procept BioRobotics stock debuts with a bang, as stock opens 40% above IPO priceMarket Watch | September 15th
Company Info
Website: https://www.procept-biorobotics.com
Address: 900 Island Drive, Redwood City, CA, United States, 94065
Sector: Healthcare
Industry: Medical Devices
Full time employees: 234
Address: 900 Island Drive, Redwood City, CA, United States, 94065
Sector: Healthcare
Industry: Medical Devices
Full time employees: 234
$PRCT yeah we're going green today
$PRCT Let’s get it
$PRCT go time
$PRCT volume is almost nonexistent